Novel Vaccine Candidate Trial Brings Science Closer to Developing a Fully Protective HIV Vaccine
On March 27, 2019, IAVI and partners launched the clinical trial of a new HIV vaccine candidate. The clinical trial named IAVI W001 is at the first step in testing the experimental vaccine in humans (Phase I) and will enroll 60 healthy […]